CUMYL-PINACA
From Wikipedia, the free encyclopedia
Legal status | |
---|---|
Legal status |
|
Identifiers | |
|
|
CAS Number | |
PubChem CID | |
ChemSpider | |
Chemical and physical data | |
Formula | C22H27N3O |
Molar mass | 349.5 g/mol |
3D model (Jmol) | |
|
|
|
CUMYL-PINACA (also known as SGT-24) is an indazole-3-carboxamide based synthetic cannabinoid. CUMYL-PINACA acts as a potent agonist for the cannabinoid receptors, with approximately 3x selectivity for CB1, having an EC50 of 0.15nM for human CB1 receptors and 0.41nM for human CB2 receptors.[1]
Legal status[edit]
Sweden's public health agency suggested to classify CUMYL-PINACA as hazardous substance on November 10, 2014.[2]
See also[edit]
References[edit]
- ^ Bowden; et al. (11 April 2013). "Patent WO 2014167530 - Cannabinoid compounds". New Zealand Patent application 623626. Retrieved 11 July 2015.
- ^ "Cannabinoider föreslås bli klassade som hälsofarlig vara". Retrieved 11 July 2015.
This cannabinoid related article is a stub. You can help Wikipedia by expanding it. |